Bon Natural Life (BON) announced a 24-month supply agreement worth $12M with Shanghai Yunsheng, China’s premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. The partnership leverages BON’s patented extraction technology to deliver science-backed formulations combining antioxidant-rich apple polyphenols with plant-based proteins, proven to support weight management and metabolic health. “As one of the world’s premier apple polyphenol suppliers, we’re leveraging our vertically integrated supply chain to dominate this high-growth niche,” said Yongwei Hu, Chairman and CEO of the Company, “the company anticipates compounding revenue streams from the ingredient’s dual applications-both as a standalone nutraceutical and as a functional food additive-while maintaining disciplined margin control to maximize shareholder returns.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BON:
- Bon Natural Life Announces Share Consolidation and Shareholder Meeting
- Bon Natural announces patent for postbiotic ingredient to regulate blood sugar
- Bon Natural Life Limited Announces $12 Million Offering
- Bon Natural Life prices 8.33M shares at $1.44 in best efforts offering
- Bon Natural Life Restructures Share Classes and Governance
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue